— Know what they know.
Not Investment Advice

CPHI AMEX

China Pharma Holdings, Inc.
1W: -14.7% 1M: -24.1% 3M: -6.1% YTD: -47.0% 1Y: -67.0% 3Y: -90.8% 5Y: -99.8%
$0.66
+0.00 (+0.61%)
 
Weekly Expected Move ±8.6%
$1 $1 $1 $1 $1
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 31 · $26.6M mcap · 40M float · 11.06% daily turnover · Short 25% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.5 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -8.7%  ·  5Y Avg: -26.7%
Cost Advantage
12
Intangibles
44
Switching Cost
53
Network Effect
24
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CPHI has No discernible competitive edge (35.5/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. Negative ROIC of -8.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CPHI receives an overall rating of C. Strongest factors: P/B (5/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 C+ C
2026-08-19 C C+
2026-08-18 C+ C
2026-04-24 C C+
2026-04-01 C- C
2026-04-01 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 12 Grade D
Profitability
3
Balance Sheet
0
Earnings Quality
47
Growth
26
Value
34
Momentum
30
Safety
0
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CPHI scores highest in Earnings Quality (47/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.75
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-3.99
Unlikely Manipulator
Ohlson O-Score
-6.26
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
CCC
Score: 18.5/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.04x
Accruals: -14.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CPHI scores -1.75, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CPHI scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CPHI's score of -3.99 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CPHI's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CPHI receives an estimated rating of CCC (score: 18.5/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.65x
PEG
0.03x
P/S
6.80x
P/B
0.08x
P/FCF
-15.78x
P/OCF
—
EV/EBITDA
-4.36x
EV/Revenue
1.60x
EV/EBIT
-1.44x
EV/FCF
-34.99x
Earnings Yield
-157.98%
FCF Yield
-6.34%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CPHI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.022
EBT / EBIT
×
EBIT Margin
-1.118
EBIT / Rev
×
Asset Turnover
0.134
Rev / Assets
×
Equity Multiplier
1.371
Assets / Equity
=
ROE
-21.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CPHI's ROE of -21.0% is driven by Asset Turnover (0.134), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.64
Median 1Y
$0.10
5th Pctile
$0.01
95th Pctile
$0.99
Ann. Volatility
152.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Zhilin Li Chairman,
Chief Executive Officer President and interim Chief Financial Officer
$300,000 $— $316,000

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
221
-4.3% YoY
Revenue / Employee
—
Profit / Employee
—
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -49.3% -48.5% -58.6% -70.6% -76.1% -77.1% -68.3% -74.6% -69.5% -52.4% -54.9% -74.9% -75.1% -62.3% -59.8% -52.7% -42.5% -20.9% -16.1% -21.0% -20.99%
ROA -18.5% -15.5% -17.9% -19.7% -21.5% -19.7% -17.8% -18.6% -19.7% -18.0% -21.2% -29.4% -32.9% -30.2% -30.0% -26.1% -21.7% -13.9% -11.9% -15.3% -15.30%
ROIC -18.8% -16.6% -17.9% -19.8% -22.0% -25.4% -19.7% -19.1% -21.3% -20.4% -22.2% -31.0% -36.8% -33.8% -34.8% -31.5% -21.7% -9.7% -7.0% -8.7% -8.73%
ROCE -42.8% -23.5% -27.5% -32.4% -84.4% -70.1% -55.8% -52.5% -32.9% -28.5% -31.2% -44.0% -52.5% -46.4% -48.7% -41.5% -32.9% -13.1% -9.1% -11.8% -11.82%
Gross Margin -15.0% 10.4% -10.6% -14.2% -7.0% 1.5% 9.1% -13.4% -12.9% -3.7% -21.2% -1.2% -47.2% -4.9% -12.0% -8.5% -7.9% 12.3% -54.9% 8.8% 8.81%
Operating Margin -38.5% -22.5% -56.8% -48.3% -35.0% -40.0% -20.3% -41.6% -39.6% -55.1% -66.9% -1.5% -98.6% -1.1% -66.8% -63.6% -83.1% -97.9% -1.1% -1.5% -1.51%
Net Margin -41.8% -33.9% -64.2% -55.1% -40.2% -43.3% -24.3% -54.0% -43.1% -57.3% -69.8% -1.6% -1.0% -1.1% -69.1% -51.5% -86.2% -99.7% -1.2% -1.5% -1.54%
EBITDA Margin 10.9% 2.2% -11.9% -5.9% -1.1% -18.1% 14.5% 21.8% -1.6% -22.6% -13.1% -70.1% -35.2% -65.8% -37.7% -17.6% -35.9% -57.3% -13.9% -34.8% -34.79%
FCF Margin 0.9% -7.1% -14.5% -30.5% -20.2% -12.2% -18.6% -16.1% -16.1% -24.4% -12.9% -11.4% -13.5% -16.7% -7.3% 1.6% -3.2% 1.2% 3.4% -4.6% -4.59%
OCF Margin 2.9% -2.6% -9.6% -23.0% -14.8% -5.1% -11.8% -11.1% -1.2% -10.0% 2.9% 5.2% -13.1% -10.3% 1.4% 9.7% 5.8% 3.6% 3.8% -4.4% -4.42%
ROE 3Y Avg snapshot only -42.80%
ROE 5Y Avg snapshot only -58.55%
ROA 3Y Avg snapshot only -22.48%
ROIC 3Y Avg snapshot only -20.63%
ROIC Economic snapshot only -8.68%
Cash ROA snapshot only -0.39%
Cash ROIC snapshot only -0.44%
CROIC snapshot only -0.45%
NOPAT Margin snapshot only -88.35%
Pretax Margin snapshot only -1.14%
R&D / Revenue snapshot only 8.51%
SGA / Revenue snapshot only 93.90%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -355.14 -339.14 -252.26 -142.16 -81.27 -77.77 -27.14 -26.05 -11.32 -9.35 -4.96 -2.69 -2.37 -2.34 -2.45 -1.60 -2.37 -1.63 -0.74 -0.63 -0.650
P/S Ratio 133.05 119.57 103.93 65.50 37.14 38.13 10.97 10.24 4.52 4.11 2.75 1.90 2.03 2.45 2.61 1.33 1.86 1.25 0.66 0.72 6.802
P/B Ratio 187.95 191.58 172.97 131.58 105.77 72.02 19.87 18.69 5.76 3.86 2.13 1.60 1.72 1.43 1.61 0.90 0.89 0.23 0.07 0.08 0.078
P/FCF 14943.93 -1675.98 -715.03 -215.11 -184.12 -312.68 -58.89 -63.42 -28.18 -16.82 -21.31 -16.62 -14.96 -14.62 -35.94 83.10 -58.29 101.82 19.46 -15.78 -15.780
P/OCF 4526.40 — — — — — — — — — 96.27 36.22 — — 183.72 13.75 32.18 35.02 17.36 — —
EV/EBITDA -5558.10 5038.19 26844.49 -63164.00 -1253.19 -376.89 -276.35 -3127.63 -1153.17 3793.35 -46.12 -11.30 -8.54 -7.16 -6.47 -4.96 -6.66 -5.52 -4.88 -4.36 -4.359
EV/Revenue 133.78 120.36 104.85 66.53 38.14 38.96 11.85 11.11 5.04 4.56 3.27 2.43 2.62 3.10 3.33 1.97 2.67 2.11 1.58 1.60 1.605
EV/EBIT -391.23 -406.14 -303.89 -173.94 -102.03 -89.23 -33.10 -32.61 -14.36 -11.66 -6.43 -3.61 -3.18 -3.07 -3.23 -2.44 -3.51 -2.83 -1.83 -1.44 -1.435
EV/FCF 15026.04 -1687.07 -721.38 -218.49 -189.05 -319.49 -63.64 -68.79 -31.40 -18.70 -25.32 -21.28 -19.35 -18.53 -45.86 122.97 -83.54 171.28 46.88 -34.99 -34.989
Earnings Yield -0.3% -0.3% -0.4% -0.7% -1.2% -1.3% -3.7% -3.8% -8.8% -10.7% -20.2% -37.2% -42.2% -42.7% -40.8% -62.6% -42.2% -61.4% -1.4% -1.6% -1.58%
FCF Yield 0.0% -0.1% -0.1% -0.5% -0.5% -0.3% -1.7% -1.6% -3.5% -5.9% -4.7% -6.0% -6.7% -6.8% -2.8% 1.2% -1.7% 1.0% 5.1% -6.3% -6.34%
PEG Ratio snapshot only 0.028
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.40 0.86 0.82 0.75 0.44 0.47 0.51 0.52 0.82 0.88 0.89 0.84 0.79 0.65 0.56 0.51 0.35 0.32 0.28 0.26 0.261
Quick Ratio 0.10 0.55 0.43 0.33 0.22 0.24 0.19 0.15 0.29 0.33 0.25 0.24 0.26 0.20 0.17 0.19 0.10 0.10 0.07 0.08 0.084
Debt/Equity 1.10 2.08 2.23 2.63 3.57 2.04 1.85 1.79 0.88 0.62 0.50 0.55 0.61 0.46 0.50 0.53 0.42 0.17 0.10 0.10 0.104
Net Debt/Equity 1.03 1.27 1.54 2.07 2.83 1.57 1.60 1.58 0.66 0.43 0.40 0.45 0.50 0.38 0.44 0.43 0.39 0.16 0.10 0.10 0.095
Debt/Assets 0.41 0.55 0.57 0.59 0.62 0.49 0.50 0.50 0.35 0.28 0.26 0.28 0.30 0.24 0.25 0.25 0.22 0.13 0.09 0.08 0.084
Debt/EBITDA -32.34 54.21 343.28 -1240.97 -41.17 -10.45 -23.84 -276.07 -158.53 549.38 -9.16 -3.02 -2.36 -1.83 -1.59 -1.97 -2.19 -2.46 -2.99 -2.60 -2.605
Net Debt/EBITDA -30.37 33.12 236.26 -977.35 -32.68 -8.03 -20.63 -244.11 -118.27 380.58 -7.31 -2.47 -1.94 -1.51 -1.40 -1.61 -2.01 -2.24 -2.86 -2.39 -2.393
Interest Coverage -10.46 -5.27 -5.15 -4.89 -4.49 -8.14 -7.78 -6.49 -7.20 -8.23 -11.01 -20.30 -26.16 -29.73 -31.61 -29.67 -28.22 -30.25 -34.44 -44.19 -44.189
Equity Multiplier 2.65 3.76 3.94 4.45 5.72 4.15 3.72 3.61 2.51 2.21 1.95 1.92 2.06 1.92 2.04 2.13 1.88 1.36 1.22 1.24 1.236
Cash Ratio snapshot only 0.040
Debt Service Coverage snapshot only -14.546
Cash to Debt snapshot only 0.081
FCF to Debt snapshot only -0.048
Defensive Interval snapshot only 50.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.49 0.44 0.43 0.43 0.47 0.40 0.44 0.47 0.49 0.41 0.38 0.42 0.38 0.29 0.28 0.31 0.28 0.18 0.13 0.13 0.134
Inventory Turnover 2.76 2.64 2.37 2.61 2.79 2.73 2.25 2.15 2.39 2.18 1.93 2.37 2.41 2.17 2.17 2.31 2.10 2.20 2.60 2.81 2.814
Receivables Turnover 19.78 15.85 18.44 22.20 18.10 14.27 17.48 38.72 19.08 15.14 14.14 36.05 15.81 12.30 12.49 16.79 14.52 17.50 15.20 17.38 17.380
Payables Turnover 11.42 8.60 8.81 15.63 16.05 10.79 9.69 19.74 12.54 8.93 9.58 28.72 12.37 10.93 10.25 15.47 8.97 7.66 6.54 6.77 6.767
DSO 18 23 20 16 20 26 21 9 19 24 26 10 23 30 29 22 25 21 24 21 21.0 days
DIO 132 138 154 140 131 133 163 170 153 167 189 154 151 168 169 158 173 166 140 130 129.7 days
DPO 32 42 41 23 23 34 38 18 29 41 38 13 30 33 36 24 41 48 56 54 53.9 days
Cash Conversion Cycle 119 119 132 133 128 125 146 161 143 150 177 152 145 164 162 156 158 139 109 97 96.8 days
Fixed Asset Turnover snapshot only 0.897
Operating Cycle snapshot only 150.7 days
Cash Velocity snapshot only 12.838
Capital Intensity snapshot only 11.423
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -11.8% -11.3% -22.5% -20.0% -16.6% -15.9% -4.8% -1.7% -3.6% -13.5% -24.1% -21.4% -28.8% -35.4% -33.1% -29.6% -26.9% -8.5% -7.1% -11.0% -10.97%
Net Income 82.2% -18.6% -23.2% 2.3% -1.7% -16.9% 6.6% 16.1% 15.7% 22.5% -4.1% -41.0% -52.5% -53.8% -28.3% 17.0% 32.8% 32.7% 22.4% -22.4% -22.39%
EPS 82.2% -14.5% -19.9% 8.6% -1.7% 13.3% 7.0% 13.0% 18.3% -4.8% -4.1% -41.0% -52.5% -53.8% -43.3% -21.1% 17.4% 25.4% 22.9% 7.0% 6.96%
FCF 1.0% 39.4% -1.2% -6.2% -19.9% -43.7% -22.0% 47.9% 23.3% -73.2% 47.4% 44.4% 39.9% 55.7% 62.4% 1.1% 82.7% 1.1% 1.4% -3.6% -3.55%
EBITDA 52.1% 1.2% -35.7% 98.8% -5.4% -4.6% -11.5% -2.3% 86.2% 1.0% -25.4% -46.6% -49.0% -233.6% -3.9% -29.7% 4.4% 19.3% 41.6% 17.3% 17.29%
Op. Income -5.6% -10.9% -15.0% 11.4% 8.6% -24.1% 1.3% 12.6% 9.7% 22.5% -7.8% -55.1% -67.3% -66.8% -35.5% 12.2% 29.3% 29.4% 18.8% -18.6% -18.56%
OCF Growth snapshot only -1.41%
Asset Growth snapshot only 2.25%
Equity Growth snapshot only 4.60%
Debt Growth snapshot only 9.54%
Shares Change snapshot only 31.55%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -9.2% -7.9% -8.6% -9.9% -10.1% -9.5% -4.6% -10.2% -10.8% -13.6% -17.6% -14.8% -17.0% -22.3% -21.5% -18.4% -20.5% -20.0% -22.2% -21.0% -21.02%
Revenue 5Y -8.1% -9.1% -10.2% -11.1% -11.2% -9.3% -9.0% -10.5% -9.7% -10.7% -11.2% -10.8% -13.0% -16.1% -15.1% -16.7% -18.1% -17.5% -19.0% -17.3% -17.28%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — -57.1% — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y -40.1% -43.9% — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y -17.7% -35.9% — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y -64.0% — — — — — — — — — — — — — — — — — — — —
FCF 5Y -46.8% — — — — — — — — — — — — — — — — — — — —
OCF 3Y -47.3% — — — — — — — — — — -13.8% — — — — — — — — —
OCF 5Y -41.4% — — — — — — — — — -26.0% -30.8% — — 5.2% — — — — — —
Assets 3Y -29.8% -20.7% -22.5% -25.3% -25.9% -7.2% -8.2% -12.2% -10.1% -8.0% -6.6% -10.6% -9.5% -13.1% -12.3% -8.4% -0.5% 20.3% 37.7% 41.7% 41.73%
Assets 5Y -26.9% -22.0% -23.1% -25.3% -26.4% -21.6% -22.5% -23.1% -21.8% -18.3% -18.6% -19.8% -19.5% -7.7% -8.7% -9.9% -5.4% 8.0% 18.0% 17.5% 17.52%
Equity 3Y -43.3% -41.6% -44.1% -48.2% -53.0% -22.6% -17.7% -19.7% -8.0% -2.3% 5.0% 4.3% -1.6% 8.8% 9.3% 17.1% 44.2% 74.4% 99.7% 1.0% 1.03%
Book Value 3Y -43.3% -42.3% -44.6% -49.4% -53.0% -30.7% -18.6% -20.5% -9.0% -3.3% 3.9% 3.3% -2.6% 8.9% 13.2% 34.4% 52.8% 99.6% 1.1% 1.1% 1.10%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.97 0.94 0.79 0.94 0.96 0.96 0.78 0.97 0.98 0.98 0.86 0.93 0.95 0.93 0.85 0.96 0.97 0.98 0.98 0.98 0.980
Earnings Stability 0.03 0.23 0.19 0.18 0.18 0.58 0.58 0.60 0.54 0.43 0.43 0.43 0.36 0.36 0.37 0.42 0.42 0.13 0.34 0.22 0.216
Margin Stability 0.52 0.54 0.31 0.05 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.00 0.00 1.00 0.00 0.00 0.50 1.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.93 0.91 0.99 0.99 0.93 0.97 0.94 0.94 0.91 0.98 0.84 0.50 0.50 0.89 0.93 0.87 0.87 0.91 0.91 0.910
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.94 0.73 0.77 0.56 0.26 -0.46 -0.18 0.04 0.41 0.33 0.28 0.23 0.18 0.06 -0.07 0.09 0.24 0.37 0.45 0.46 0.456
Gross Margin Trend -0.06 -0.12 -0.15 -0.19 -0.14 -0.17 -0.10 -0.03 -0.04 -0.03 -0.10 -0.25 -0.34 -0.39 -0.36 -0.04 0.11 0.21 0.14 0.14 0.135
FCF Margin Trend 0.06 -0.04 -0.10 -0.25 -0.09 -0.03 -0.09 -0.03 -0.06 -0.15 0.04 0.12 0.05 0.02 0.09 0.15 0.12 0.22 0.13 0.00 0.003
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.08 0.07 0.23 0.50 0.32 0.10 0.29 0.28 0.03 0.23 -0.05 -0.07 0.15 0.10 -0.01 -0.12 -0.07 -0.05 -0.04 0.04 0.039
FCF/OCF 0.30 2.75 1.52 1.32 1.37 2.41 1.58 1.46 13.47 2.45 -4.52 -2.18 1.03 1.63 -5.11 0.17 -0.55 0.34 0.89 1.04 1.037
FCF/Net Income snapshot only 0.040
CapEx/Revenue 2.0% 4.5% 4.9% 7.4% 5.4% 7.1% 6.8% 5.1% 14.9% 14.4% 15.8% 16.6% 0.4% 6.4% 8.7% 8.1% 9.0% 2.3% 0.4% 0.2% 0.16%
CapEx/Depreciation snapshot only 0.002
Accruals Ratio -0.20 -0.14 -0.14 -0.10 -0.15 -0.18 -0.13 -0.13 -0.19 -0.14 -0.22 -0.32 -0.28 -0.27 -0.30 -0.29 -0.23 -0.15 -0.12 -0.15 -0.147
Sloan Accruals snapshot only -0.207
Cash Flow Adequacy snapshot only -27.134
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio 0.0% — — — — — — — — — — — — — — 0.0% — 0.0% 0.0% — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.10 1.19 1.19 1.20 1.22 1.12 1.13 1.15 1.14 1.12 1.09 1.05 1.04 1.03 1.03 1.03 1.04 1.03 1.03 1.02 1.022
EBIT Margin -0.34 -0.30 -0.35 -0.38 -0.37 -0.44 -0.36 -0.34 -0.35 -0.39 -0.51 -0.67 -0.82 -1.01 -1.03 -0.80 -0.76 -0.74 -0.86 -1.12 -1.118
Asset Turnover 0.49 0.44 0.43 0.43 0.47 0.40 0.44 0.47 0.49 0.41 0.38 0.42 0.38 0.29 0.28 0.31 0.28 0.18 0.13 0.13 0.134
Equity Multiplier 2.67 3.12 3.27 3.59 3.55 3.92 3.84 4.01 3.53 2.92 2.59 2.55 2.28 2.06 1.99 2.02 1.96 1.51 1.35 1.37 1.371
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.79 $-0.71 $-0.77 $-0.75 $-0.80 $-0.62 $-0.72 $-0.66 $-0.65 $-0.65 $-0.75 $-0.93 $-1.00 $-1.00 $-1.07 $-1.12 $-0.82 $-0.74 $-0.83 $-1.04 $-1.04
Book Value/Share $1.49 $1.26 $1.13 $0.82 $0.61 $0.67 $0.98 $0.91 $1.28 $1.57 $1.74 $1.56 $1.37 $1.63 $1.64 $1.98 $2.19 $5.30 $8.67 $8.43 $8.43
Tangible Book/Share $1.36 $1.14 $1.00 $0.71 $0.51 $0.32 $0.51 $0.48 $0.86 $0.80 $0.71 $0.55 $0.37 $0.14 $0.00 $-0.11 $-0.07 $-0.41 $-0.34 $-0.50 $-0.50
Revenue/Share $2.10 $2.02 $1.88 $1.64 $1.75 $1.26 $1.78 $1.67 $1.64 $1.47 $1.35 $1.31 $1.17 $0.95 $1.01 $1.35 $1.05 $0.97 $0.93 $0.91 $0.91
FCF/Share $0.02 $-0.14 $-0.27 $-0.50 $-0.35 $-0.15 $-0.33 $-0.27 $-0.26 $-0.36 $-0.17 $-0.15 $-0.16 $-0.16 $-0.07 $0.02 $-0.03 $0.01 $0.03 $-0.04 $-0.05
OCF/Share $0.06 $-0.05 $-0.18 $-0.38 $-0.26 $-0.06 $-0.21 $-0.19 $-0.02 $-0.15 $0.04 $0.07 $-0.15 $-0.10 $0.01 $0.13 $0.06 $0.03 $0.04 $-0.04 $-0.03
Cash/Share $0.10 $1.02 $0.78 $0.45 $0.45 $0.32 $0.25 $0.19 $0.29 $0.30 $0.18 $0.16 $0.15 $0.13 $0.10 $0.19 $0.08 $0.08 $0.04 $0.07 $0.07
EBITDA/Share $-0.05 $0.05 $0.01 $-0.00 $-0.05 $-0.13 $-0.08 $-0.01 $-0.01 $0.00 $-0.10 $-0.28 $-0.36 $-0.41 $-0.52 $-0.53 $-0.42 $-0.37 $-0.30 $-0.34 $-0.34
Debt/Share $1.63 $2.61 $2.52 $2.14 $2.19 $1.36 $1.82 $1.64 $1.13 $0.97 $0.88 $0.85 $0.84 $0.75 $0.82 $1.05 $0.92 $0.91 $0.90 $0.87 $0.87
Net Debt/Share $1.53 $1.60 $1.73 $1.69 $1.74 $1.05 $1.57 $1.45 $0.85 $0.67 $0.70 $0.70 $0.69 $0.62 $0.73 $0.86 $0.84 $0.83 $0.86 $0.80 $0.80
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -1.748
Altman Z-Prime snapshot only -4.774
Piotroski F-Score 4 2 2 2 4 2 4 6 4 5 5 5 3 3 5 6 6 6 4 4 4
Beneish M-Score -4.20 -2.15 -4.47 -3.77 -2.70 0.86 -2.45 -1.64 -2.51 -2.81 -4.28 -4.06 -3.48 -4.38 -3.46 3.14 -0.91 -3.26 -3.03 -3.99 -3.994
Ohlson O-Score snapshot only -6.256
Net-Net WC snapshot only $-1.52
EVA snapshot only $-7421101.31
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 46.34 35.97 35.79 43.89 43.07 45.26 19.25 19.17 18.59 8.94 19.09 18.93 16.92 18.10 17.06 18.14 17.74 19.96 19.74 18.45 18.453
Credit Grade snapshot only 17
Credit Trend snapshot only 0.315
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 8
Sector Credit Rank snapshot only 8

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms